Clinical Trial

Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETs

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Evaluate the diagnostic efficacy, pharmacokinetics and safety of 68Ga-DOTATATE injection PET/CT in NETs
Trial Details
NCT Number NCT07119242
Lead Sponsor HTA Co., Ltd.
Conditions NETs
Enrollment 95 participants
Start Date 2024-01-08
Primary Completion 2024-11-11 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-13